Newsletter: Foundations of Heart Health in the Philippines – Nutrition, Movement and Mindfulness

[THIS IS A PRESS RELEASE]

We live in an era powered by information, with scientific breakthroughs, advancing technology, rising awareness, and economic progress shaping the way we live and care for ourselves. As access to healthcare improves and health related conversations become more mainstream, one would assume this would translate into fewer health issues. Yet, ironically, cardiovascular health continues to pose a significant challenge and remains the leading cause of death in the Philippines, accounting for nearly one in five deaths in 2024 according to the Philippine Statistics Authority (PSA).

Newsletter: Small Shifts, Big Results: How Women in APAC Could Enhance Wellness Through Balanced Nutrition and Lifestyle

[THIS IS A PRESS RELEASE]

By Dr. Rocio Medina Badiano, Cochairperson and Member, Herbalife Nutrition Advisory Board

In today’s fast-paced societies across Asia Pacific, women are increasingly balancing multiple responsibilities—at home, at work, and within their communities. Amidst these demands, finding time to prioritize health and wellness can be a challenge. Yet, emerging science and real-world experience consistently show that even modest, well-informed changes in daily habits—particularly around nutrition—can lead to meaningful, long-term improvements in well-being.

Newsletter: Almost 9 out of 10 Filipinos Take Supplements, Making the Philippines APAC’s Top Supplement Market – Herbalife Survey

[THIS IS A PRESS RELEASE]

Herbalife, a premier health and wellness company, community and platform, has released findings from its 2025 Asia Pacific Responsible Supplementation Survey, revealing that Filipinos (89%) are the top health supplement users in the region, followed by Indonesia (88%) and Taiwan (86%). The survey showed that most Filipinos take health supplements to support their general health and immunity (70%), followed by for energy and focus (42%) and for better sleep or stress management (35%).